|

Immunotherapy (nivolumab and relatlimab) Clinical Trials

1 actively recruiting trial across 1 location

Pipeline

Phase 2/3: 1

Top Sponsors

  • Linnaeus Therapeutics, Inc.1

Indications

  • Melanoma Stage IIIB-IV1
  • Melanoma (Skin Cancer)1
  • Unresectable Melanoma1
  • Cutaneous Melanoma1
  • Cancer1

Newport Beach, California1 trial

A Trial of LNS8801 With or Without Pembrolizumab in Patients With Refractory Melanoma

USC Newport Beach

Phase 2/3

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.